Structural Changes in the Arginine Vasopressin Molecule that Enhance Antidiuretic Activity and Specificity1
The DOI matches its Crossref record.
Abstract
Three structural changes in the arginine varopressin (AVP) molecule are known to enhance antidiuretic specificity by increasing the ratio of antidiuretic to vasopressor activities (A⁄V ratio). These are: (a) substitution of an amino acid with a smaller and less hydrophilic amino acid side chain for the 4-glutamine, (b) substitution of H for the N-terminal free amino group (deamination) and (c) substitution of Dfor L-arginine in the 8-position. We have synthesized and studied several analogs of AVP in which these three changes have been made singly and in various combinations. We prepared 4- valine analogs since these had not been studied before. Its highly hydrophobic side chain made valine an obvious choice with which to test further the hypothesis that the lipophilic character of the side chain on the amino acid in the 4-position plays a key role in endowing vasopressin analogs with enhanced antidiuretic specificity. Substitution of valine for glutamine did indeed enhance specificity, most strikingly when valine was substituted in peptides containing an 8-D-arginine. When all three changes, (a), (b) and (c) were combined for the first time in a single molecule, 11-deamino, 4-valine, 8-D-arginine]-vasopressin or dVDAVP their effects were cumulative. dVDAVP has undetectable vasopressor activity, antidiuretic activity about four times that of AVP, and an unprecedented A⁄V ratio of over 123,000, compared to 0.9 for AVP. It also has greatly prolonged antidiuretic action in conscious rats. Studies on dVDAVP and related analogs may provide new insights into the structural specificities of AVP receptors and into the mechanisms that terminate antidiuretic responses. (Endocrinology94: 1106, 1974)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Merrifield, R. B. (1969) · Advances in Enzymology - and Related Areas of Molecular Biology · doi:10.1002/9780470122778.ch6 · Cited by 638
Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics
Manning, M., Misicka, A., Olma, A., Bankowski, K., Stoev, S., Chini, B., Durroux, T., Mouillac, B., Corbani, M., & Guillon, G. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02303.x · Cited by 423
Self-citationMANNING, M., STOEV, S., CHINI, B., DURROUX, T., MOUILLAC, B., & GUILLON, G. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00437-8 · Cited by 296
Self-citationDrugs Five Years Later: Desmopressin
RICHARDSON, D. W., & ROBINSON, A. G. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-2-228 · Cited by 272
A V1-like receptor mediates vasopressin-induced flank marking behavior in hamster hypothalamus
Albers, H., Pollock, J., Simmons, W., & Ferris, C. (1986) · The Journal of Neuroscience · doi:10.1523/jneurosci.06-07-02085.1986 · Cited by 112
“Chan and du Vigneaud, 1962 Smith et al., 1980 Fenier et al., 1965 Walter et al., 1976 Sawyer et al., 1974”
Background
Metadata
- Authors
- SAWYER, W. H., ACOSTA, M., BALASPIRI, L., JUDD, J., & MANNING, M.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1974-04
- Volume
- 94
- Issue
- 4
- Pages
- 1106-1115
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2048965703
- Cited by
- 134
- References
- 0
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Structural Changes in the Arginine Vasopressin Molecule that Enhance Antidiuretic Activity and Specificity1. https://app.cochat.ai/papers/10.1210/endo-94-4-1106
- The paper
- SAWYER, W. H., ACOSTA, M., BALASPIRI, L., JUDD, J., & MANNING, M. (1974). Structural Changes in the Arginine Vasopressin Molecule that Enhance Antidiuretic Activity and Specificity1. Endocrinology. https://doi.org/10.1210/endo-94-4-1106
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.